(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CURIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CURIA

ST13

US500000088880211

Class

9, 42

Filing

88880211

Registration

6909290

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

11/29/2022

Trademark type

Combined

Nice classes

9, 42

Filing date

04/21/2020

Registration date

11/29/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/29/2022

Last transaction

11/29/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

3

Owner type

99

Owner location

Eschborn, DE

Examiner

SALCIDO, JOHN

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "CURIA" in standard block letters. A representation of a heart and stethoscope to the left of the word mark. The heart, stethoscope, and the wording all start in pink on the left and transition to purple on the right. The bell of the stethoscope is over the heart and is white.

Holders and representatives

Holders

Innoplexus AG

Representatives

Geza C. Ziegler, Jr. ZIEGLER IP LAW GROUP, LLC

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable software for use in database management relating to the field of science and medicinethe database relating to medicinespharmaceutical and clinical trialsmedical and healthcare professionals; Computer software namelydownloadable computer software for use in database management relating to the field of science and medicinein particularthe database relating to medicinesclinical trialsmedical and healthcare professionals; Computer software relating to the medical field namelydownloadable computer software for use in database management relating to the field of science and medicinethe database relating to medicinespharmaceutical and clinical trialsmedical and healthcare professionals; Downloadable mobile applications for providing information related to the field of science and medicinethe information relating to medicinespharmaceutical and clinical trialsmedical and healthcare professionalsscheduling medical appointments and online consultation with medical and healthcare professionals; Software applications for use with mobile devicesdownloadable computer software for use in database management relating to the field of science and medicinethe database relating to medicinespharmaceutical and clinical trialsmedical and healthcare professionals; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software for authorising access to data bases; Downloadable computer application software for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases; Downloadable mobile applications for providing information related to life sciences and pharma domain using proprietary and non-proprietary databases; Downloadable mobile applications for the management of information; Downloadable mobile applications for the transmission of information

Class 42

Medical research services; Medical and pharmacological research services; Research on the subject of pharmaceuticals; Computer programming in the medical field; Scientific investigations for medical purposes; Scientific research for medical purposes in the area of cancerous diseases; Research and development in the pharmaceutical and biotechnology fields; Providing scientific information in the field of medical disorders and their treatment; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Computer software relating to the medical fieldproviding on-line non-downloadable software for use in database management relating to the field of science and medicinethe database relating to medicinespharmaceutical and clinical trialsmedical and healthcare professionals; Software applications for use with mobile devicesproviding temporary use of a web-based software application for use in database management relating to the field of science and medicinethe database relating to medicinespharmaceutical and clinical trialsmedical and healthcare professionals

Publications

History of USPTO decisions and trademark events.

39 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/29/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/29/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/13/2022

PUBO

PUBLISHED FOR OPPOSITION

09/13/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/24/2022

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

08/09/2022

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

08/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/01/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/26/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/26/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/26/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/18/2022

GNRT

NON-FINAL ACTION E-MAILED

04/18/2022

CNRT

NON-FINAL ACTION WRITTEN

04/18/2022

DOCK

ASSIGNED TO EXAMINER

04/18/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/15/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

03/15/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/06/2022

GNSL

LETTER OF SUSPENSION E-MAILED

01/06/2022

CNSL

SUSPENSION LETTER WRITTEN

01/06/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/26/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/26/2021

ALIE

ASSIGNED TO LIE

11/26/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

11/22/2021

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

07/26/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/21/2021

GNSL

LETTER OF SUSPENSION E-MAILED

01/21/2021

CNSL

SUSPENSION LETTER WRITTEN

01/21/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/20/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/20/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/20/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/20/2020

GNRT

NON-FINAL ACTION E-MAILED

07/20/2020

CNRT

NON-FINAL ACTION WRITTEN

07/20/2020

DOCK

ASSIGNED TO EXAMINER

07/14/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/30/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/29/2020

NWAP

NEW APPLICATION ENTERED

04/24/2020

Continuous trademark protection

Get notified about every new filing that threatens CURIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.